Cargando…

Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

BACKGROUND: Trastuzumab plus docetaxel is a mainstay to treat HER2-positive breast cancers. However, developing nanoparticles could help to improve the efficacy/toxicity balance of this doublet by improving drug trafficking and delivery to tumors. This project aimed to develop an immunoliposome in b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodallec, Anne, Brunel, Jean-Michel, Giacometti, Sarah, Maccario, Helene, Correard, Florian, Mas, Eric, Orneto, Caroline, Savina, Ariel, Bouquet, Fanny, Lacarelle, Bruno, Ciccolini, Joseph, Fanciullino, Raphaelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014390/ https://www.ncbi.nlm.nih.gov/pubmed/29950829 http://dx.doi.org/10.2147/IJN.S162454

Ejemplares similares

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018)

Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles
por: Rodallec, A., et al.
Publicado: (2020)

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
por: Sicard, Guillaume, et al.
Publicado: (2020)

In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation
por: Fanciullino, R, et al.
Publicado: (2007)

Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
por: Rodallec, Anne, et al.
Publicado: (2022)

In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling
por: Mollard, Séverine, et al.
Publicado: (2016)

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer [Erratum]
Publicado: (2018)

COVID-19 vaccine race: watch your step for cancer patients
por: Fanciullino, Raphaelle, et al.
Publicado: (2020)

Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors
por: Vaghi, Cristina, et al.
Publicado: (2020)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept
por: Bitounis, Dimitrios, et al.
Publicado: (2012)

Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
por: Sicard, Guillaume, et al.
Publicado: (2020)

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
por: Pasquier, Eddy, et al.
Publicado: (2011)

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
por: Bianchini, Giampaolo, et al.
Publicado: (2017)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells
por: Moreira, Thais da Silva, et al.
Publicado: (2023)

Trastuzumab–Docetaxel Combination Chemotherapy Induced Severe Onychopathy
por: Sonthalia, Sidharth, et al.
Publicado: (2017)

The Stealth Virus
por: Tang, Julian W.
Publicado: (2013)

Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma
por: Imbs, Diane‐Charlotte, et al.
Publicado: (2017)

Immunoliposomes for detection of rupture-prone intracranial aneurysms
por: Jahromi, Behnam Rezai, et al.
Publicado: (2023)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)

Stealth physics at LHCb
Publicado: (2020)

The herpesvirus stealth program
por: Huang, Teng, et al.
Publicado: (2015)

Tobacco Marketing by Stealth
por: Munafò, Marcus
Publicado: (2016)

‘Stealth’ Prostate Tumors
por: Wagaskar, Vinayak G., et al.
Publicado: (2023)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

LHCb Results in Stealth Physics
por: Ilten, Philip James
Publicado: (2020)

Stigma: The Stealth Weapon of the NTD
por: Hotez, Peter J.
Publicado: (2008)

The stealth model at LEP2
por: Binoth, T, et al.
Publicado: (1995)

Gene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma
por: Végran, F, et al.
Publicado: (2009)

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
por: Xu, Qiaoping, et al.
Publicado: (2021)

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
por: Koukourakis, M I, et al.
Publicado: (2002)

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
por: Vingerhoeds, M. H., et al.
Publicado: (1996)

Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors
por: Urbán, Patricia, et al.
Publicado: (2011)

Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system
por: He, Junkun, et al.
Publicado: (2012)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
por: Zheng, Zhong, et al.
Publicado: (2019)

Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force
por: Thomsen, Louiza Bohn, et al.
Publicado: (2019)

Novel method for screening functional antibody with comprehensive analysis of its immunoliposome
por: Hamamichi, Shusei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0ppqrh3jur22edsk0a224ae2e2